Tag: PEGASUS-TIMI 54

Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

A new subanalysis of the phase III PEGASUS-TIMI 54 trial indicates that ticagrelor (Brilique, As...